Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide
Adjuvants, Immunologic
Animals
Cytokines
/ genetics
Female
Gels
Immunity, Humoral
/ immunology
Immunization, Secondary
/ veterinary
Immunoglobulin Isotypes
/ classification
Influenza A Virus, H3N8 Subtype
/ immunology
Influenza Vaccines
/ immunology
Lung
/ pathology
Mannitol
/ analogs & derivatives
Mice
Mice, Inbred BALB C
Oleic Acids
/ immunology
RNA, Messenger
/ analysis
Trachea
/ pathology
Turbinates
/ pathology
Vaccines, Inactivated
/ immunology
Vaccines, Synthetic
/ immunology
MontanideTM pet gel
adjuvant
equine influenza
reverse genetics
vaccine
Journal
The Journal of veterinary medical science
ISSN: 1347-7439
Titre abrégé: J Vet Med Sci
Pays: Japan
ID NLM: 9105360
Informations de publication
Date de publication:
18 Dec 2019
18 Dec 2019
Historique:
pubmed:
28
10
2019
medline:
5
6
2020
entrez:
29
10
2019
Statut:
ppublish
Résumé
Equine influenza is a leading cause for respiratory illness in equines. Major control measures involve vaccination which requires continuous harmonization owing to antigenic drift. The present study focused on assessing the protective efficacy of an inactivated recombinant equine influenza virus (rgEIV) vaccine candidate adjuvanted with Montanide
Identifiants
pubmed: 31656240
doi: 10.1292/jvms.19-0399
pmc: PMC6943333
doi:
Substances chimiques
Adjuvants, Immunologic
0
Cytokines
0
Gels
0
Immunoglobulin Isotypes
0
Influenza Vaccines
0
Oleic Acids
0
RNA, Messenger
0
Vaccines, Inactivated
0
Vaccines, Synthetic
0
montanide ISA 51
0
Mannitol
3OWL53L36A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1753-1762Références
J Immunol. 2004 May 1;172(9):5269-76
pubmed: 15100265
J Immunol. 1997 Dec 1;159(11):5197-200
pubmed: 9548456
PLoS One. 2015 Nov 20;10(11):e0143094
pubmed: 26587990
J Exp Med. 2009 Jan 16;206(1):69-78
pubmed: 19139170
J Clin Invest. 1996 Aug 1;98(3):715-22
pubmed: 8698863
Pharmaceutics. 2019 Mar 25;11(3):null
pubmed: 30934594
Infect Immun. 2003 Dec;71(12):6915-20
pubmed: 14638780
J Virol. 2005 Oct;79(19):12401-7
pubmed: 16160167
Vaccine. 2006 May 8;24(19):4047-61
pubmed: 16545507
Equine Vet J. 1993 Nov;25(6):537-8
pubmed: 8276003
Vet Microbiol. 2010 Jul 14;143(2-4):224-37
pubmed: 20053509
Microb Pathog. 2016 Aug;97:172-7
pubmed: 27296706
Vaccine. 2017 Aug 3;35(34):4430-4436
pubmed: 28687406
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
pubmed: 10801978
Vet Immunol Immunopathol. 2014 Feb 15;157(3-4):164-74
pubmed: 24445196
Eur J Immunol. 1995 Mar;25(3):823-9
pubmed: 7705414
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16825-9
pubmed: 16267134
Virology. 2008 Jun 20;376(1):53-9
pubmed: 18420248
Vet Microbiol. 2017 Oct;210:188-196
pubmed: 29103691
Equine Vet J. 2013 Nov;45(6):768-9
pubmed: 24117935
Mol Immunol. 2014 Oct;61(2):79-88
pubmed: 25001046
Arch Virol. 2001;146(6):1063-74
pubmed: 11504416
Scand J Immunol. 2006 Nov;64(5):467-75
pubmed: 17032238
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8432-7
pubmed: 21536880
Vaccine. 1997 Jun;15(9):1039-44
pubmed: 9261954